Status:
RECRUITING
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Traumatic Brain Injury
Subarachnoid Hemorrhage
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to examine the safety and feasibility of using hyperpolarized metabolic MRI to study early brain metabolism changes in subjects presenting with head injury and suspected n...
Eligibility Criteria
Inclusion
- History of acute head injury with or suspected non-penetrating acute TBI
- Suitable to undergo contrast-enhanced MRI
- Negative serum pregnancy test
Exclusion
- Inability to undergo MRI scan
- Inability to receive IV MRI contrast agents secondary to severe reaction or renal insufficiency
- Positive pregnancy test
Key Trial Info
Start Date :
October 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 26 2027
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06103201
Start Date
October 26 2023
End Date
November 26 2027
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201